Skip to main content

The Effect of 1600 μg Inhaled Salbutamol Administration on 30 m Sprint Performance Pre and Post a Yo-Yo Intermittent Running Test in Football Players

Merlini, Michele, Marco, Beato, Marcora, Samuele, Dickinson, John (2019) The Effect of 1600 μg Inhaled Salbutamol Administration on 30 m Sprint Performance Pre and Post a Yo-Yo Intermittent Running Test in Football Players. Journal of Sports Science and Medicine, 18 . ISSN 1303-2968. (KAR id:77428)

PDF Publisher pdf
Language: English
Download (360kB) Preview
[thumbnail of merlini JSSM 2019.pdf]
Preview
This file may not be suitable for users of assistive technology.
Request an accessible format
Official URL
https://www.jssm.org/hfabst.php?id=jssm-18-716.xml

Abstract

The purpose of the study was to investigate the effect of inhaling 1600 μg of salbutamol (SAL) on 30 m sprint before and after the Yo-Yo Intermittent Recovery test. In a randomised cross over single blind study 13 male non-asthmatic, football players volunteered (mean ± SD; age 18.1 ± 0.9 years; weight 69.5 ± 8.3 kg; height 1.78 ± 0.07 m). Participants completed two visits and were randomly assigned to either (SAL) or (PLA) treatment and performed a set of three sprints of 30 m before and after the Yo-Yo Intermittent Recovery Test (Yo-Yo IRT). Best sprint and mean sprint were analysed in addition to the distance covered during the Yo-Yo IRT; rating of perceived exertion and heart rate were collected at the end of each level completed. Repeated measures ANOVA were performed to investigate changes in performance between groups. Following the inhalation of supra-therapeutic salbutamol dose (1600 μg) neither 30 m sprint time (PLA 4.43 ± 0.14 s; SAL 4.44 ± 0.15 s, p = 0.76) nor distance covered in the Yo-Yo IRT test reported significant variation between PLA conditions (1660 ± 217 m) and SAL (1610 ± 229 m, p = 0.16). Moreover, lactate values, heart rate and RPE did not differ significantly between groups. The inhalation of 1600 μg salbutamol does not enhance 30 m sprint performance in non-fatigued and fatigue conditions. Our findings suggest when football players acutely inhale double the permitted dose of salbutamol, as indicated in the World Anti-Doping Agency List of Prohibited Substances and Methods, they will not experience improvements in sprint or endurance performance.

Item Type: Article
Uncontrolled keywords: Football, salbutamol, sprint, asthma, doping
Subjects: R Medicine > RC Internal medicine > RC1200 Sports medicine
Divisions: Divisions > Division of Natural Sciences > School of Sport and Exercise Sciences
Depositing User: John Dickinson
Date Deposited: 14 Oct 2019 13:41 UTC
Last Modified: 16 Feb 2021 14:08 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/77428 (The current URI for this page, for reference purposes)
Marcora, Samuele: https://orcid.org/0000-0002-1570-7936
Dickinson, John: https://orcid.org/0000-0002-1824-7402
  • Depositors only (login required):

Downloads

Downloads per month over past year